Investor Relations
Press Releases
Stock Price
Events
2013 Future Leaders in the Biotech Industry Conference
April 5, 2013, 11 a.m. Eastern
New York, NY
Read More...About
We are a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health.
Our current product pipeline (with the respective status of development) consists of the following:
Androxal®
Male Reproductive Health
Proellex®
Female Reproductive Health
Read More...
Pipeline
